Schonfeld Strategic Advisors’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,200	Closed	-$185K	–	2341
2021 Q3	$185K	Buy	+22,200	New	+$185K	﹤0.01%	1715